Cancer Screening
VIDEO: Potential of AI in breast cancer diagnostics
In this video interview, Sara M. Tolaney, MD, MPH, highlights the integration of artificial intelligence in radiologic reads to assist technicians in detecting abnormalities during breast cancer screenings.
Q&A: 'Convenience is a major selling point' for new colorectal cancer blood test
The new blood test screening option for colorectal cancer is innovative and could improve screening uptake, but it also has some drawbacks, according to an expert.
Revised criteria may ‘substantially reduce racial disparities’ in lung cancer screening
Alternative lung cancer screening criteria may identify more individuals, who would benefit from screening compared with current guidelines, study results showed.
‘Popularity paradox’: Evidence lacking to support lung cancer screening for never-smokers
Current evidence does not support lung cancer screening for never-smokers or former light smokers with a family history of lung cancer, according to a commentary in Journal of Thoracic Oncology.
New ACG, ASGE quality indicators for colonoscopy include 3 key updates
Revised quality indicators released by the ACG and ASGE highlight the importance of adenoma and sessile serrated lesion detection rates as well as adequate bowel preparation for improving the technical performance of colonoscopy.
Messaging strategies increase support for, intentions of breast cancer screening cessation
Among older women, messaging strategies significantly increased support for and intentions of breast cancer screening cessation, with the strongest effects occurring when messages were delivered over time from multiple sources, data show.
Low education level raises risk for loss to follow-up in lung cancer screening program
Having an education level of high school or less heightened the risk for loss to follow-up among individuals eligible for lung cancer screening, according to a letter published in Annals of the American Thoracic Society.
Lung cancer screening judgement strongly influenced by clinicians
During lung cancer screening selection assessments, clinicians influenced the decision of screening inappropriateness more than patient factors, according to results published in American Journal of Respiratory and Critical Care Medicine.
FIT screenings linked to 33% lower mortality risk from colorectal cancer
Completing at least one fecal immunochemical test screening correlated with a 33% overall lower risk for death from colorectal adenocarcinoma, with a 42% reduction reported for cancers in the left colon and rectum, according to researchers.
‘Tremendous leap forward’: FDA approves first colorectal cancer blood test
The FDA has approved Guardant Health’s Shield blood test to screen for colorectal cancer in patients aged 45 years and older at average risk for disease, according to a company press release.